Revvity Share Holder Equity 2010-2024 | RVTY

Revvity share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Revvity share holder equity for the quarter ending September 30, 2024 was $7.870B, a 0% increase year-over-year.
  • Revvity share holder equity for 2023 was $7.873B, a 6.64% increase from 2022.
  • Revvity share holder equity for 2022 was $7.383B, a 3.38% increase from 2021.
  • Revvity share holder equity for 2021 was $7.141B, a 91.17% increase from 2020.
Revvity Annual Share Holder Equity
(Millions of US $)
2023 $7,873
2022 $7,383
2021 $7,141
2020 $3,735
2019 $2,814
2018 $2,585
2017 $2,503
2016 $2,154
2015 $2,110
2014 $2,042
2013 $1,994
2012 $1,940
2011 $1,842
2010 $1,925
2009 $1,629
Revvity Quarterly Share Holder Equity
(Millions of US $)
2024-06-30 $7,870
2024-03-31 $7,846
2023-12-31 $7,873
2023-09-30 $7,694
2023-06-30 $7,870
2023-03-31 $8,034
2022-12-31 $7,383
2022-09-30 $7,065
2022-06-30 $7,167
2022-03-31 $7,186
2021-12-31 $7,141
2021-09-30 $6,959
2021-06-30 $4,240
2021-03-31 $4,002
2020-12-31 $3,735
2020-09-30 $3,232
2020-06-30 $2,967
2020-03-31 $2,760
2019-12-31 $2,814
2019-09-30 $2,707
2019-06-30 $2,707
2019-03-31 $2,638
2018-12-31 $2,585
2018-09-30 $2,572
2018-06-30 $2,517
2018-03-31 $2,555
2017-12-31 $2,503
2017-09-30 $2,536
2017-06-30 $2,439
2017-03-31 $2,209
2016-12-31 $2,154
2016-09-30 $2,135
2016-06-30 $2,088
2016-03-31 $2,049
2015-12-31 $2,110
2015-09-30 $2,054
2015-06-30 $2,121
2015-03-31 $2,060
2014-12-31 $2,042
2014-09-30 $2,063
2014-06-30 $2,056
2014-03-31 $2,029
2013-12-31 $1,994
2013-09-30 $1,920
2013-06-30 $1,860
2013-03-31 $1,834
2012-12-31 $1,940
2012-09-30 $1,942
2012-06-30 $1,885
2012-03-31 $1,883
2011-12-31 $1,842
2011-09-30 $1,945
2011-06-30 $1,956
2011-03-31 $1,908
2010-12-31 $1,925
2010-09-30 $1,707
2010-06-30 $1,644
2010-03-31 $1,631
2009-12-31 $1,629
2009-09-30 $1,602
2009-06-30 $1,574
2009-03-31 $1,512
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00